Table 1.
Patient characteristics of all enrolled cases
| Number of cases (%) | ||
| Age | Mean | 59.5 |
| Range | 38–75 | |
| Gender | Male | 24 (68.8) |
| Female | 11 (31.3) | |
| Histology | Adenocarcinoma | 25 (71.4) |
| Squamous cell carcinoma | 8 (22.9) | |
| Large cell carcinoma | 1 (2.9) | |
| Atypical carcinoid | 1 (2.9) | |
| Performance status | 0 | 3 (8.6) |
| 1 | 32 (91.4) | |
| Clinical staging | c-stage IIIB | 6 (17.1) |
| c-stage IV | 20 (57.1) | |
| Recurrence | 9 (25.7) | |
| EGFR mutation status | Wild | 28 (80) |
| Mutation | 7 (20) | |
| Prior treatment | Platinum-based chemotherapy | 30 (85.7) |
| Gefitinib | 5 (14.3) | |
| Surgery | 11 (31.4) | |
| Radiation therapy | 11 (31.4) |